MedPath

A randomized trial of shortterm inpatient Dialectic Behaviour Treatment (DBT)versus longterm outpatient DBT

Withdrawn
Conditions
severe personality disorder/ suicidal behaviour / self-destructive behaviour
10034726
Registration Number
NL-OMON34525
Lead Sponsor
Rivierduinen Centrum Persoonlijkheidsstoornissen Jelgersma
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Withdrawn
Sex
Not specified
Target Recruitment
54
Inclusion Criteria

adult borderline patients with suicidal behaviour and selfdestructive behaviour with at least 6 diagnostic criteria of the DSM IV TR criteria of the borderling personality disorder

Exclusion Criteria

IQ< 80
a chronic psychotic state
a bipolar disorder
addiction

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Measurements: Different diagnostic instruments will be used (SCID-I, SCID-II,<br /><br>interview for treatment history and the LPC, next to the instruments that<br /><br>measure the symptomatology (SCL-90, BDPSI, BDI, BDHI, etc.), attachment style<br /><br>and quality of life. In more detail: the severity of the borderline pathology<br /><br>is indicated by the BPDSI (Arntz et. al., 2003). Measurement of treatment<br /><br>effect will be linked to routine outcome monitoring (ROM) used in the<br /><br>Rivierduinen.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>reduction of general psychiatric symptoms<br /><br><br /><br>Quality of live</p><br>
© Copyright 2025. All Rights Reserved by MedPath